90 related articles for article (PubMed ID: 26676887)
1. Tumor-related gene expression levels in thymic carcinoma and Type B3 thymoma.
Karube Y; Kobayashi S; Maeda S; Sado T; Ishihama H; Chida M
J Cardiothorac Surg; 2016 May; 11(1):85. PubMed ID: 27387303
[TBL] [Abstract][Full Text] [Related]
2. Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan.
Meisenberg C; Gilbert DC; Chalmers A; Haley V; Gollins S; Ward SE; El-Khamisy SF
Mol Cancer Ther; 2015 Feb; 14(2):575-85. PubMed ID: 25522766
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the mRNA expression of chemotherapy-related genes in colorectal carcinoma using the danenberg tumor profile method.
Sasaki S; Watanabe T; Nakayama H
J Oncol; 2013; 2013():386906. PubMed ID: 23577026
[TBL] [Abstract][Full Text] [Related]
4. Exploring the impact of MiR-92a-3p on FOLFOX chemoresistance biomarker genes in colon cancer cell lines.
Escalante PI; Quiñones LA; Contreras HR
Front Pharmacol; 2024; 15():1376638. PubMed ID: 38659583
[No Abstract] [Full Text] [Related]
5. Impact of dihydropyrimidine dehydrogenase and γ-glutamyl hydrolase on the outcomes of patients treated with gemcitabine or S-1 as adjuvant chemotherapy for advanced pancreatic cancer.
Nakamura A; Hayashi K; Nakajima G; Kamikozuru H; Okuyama R; Kuramochi H; Hatori T; Yamamoto M
Exp Ther Med; 2011 Nov; 2(6):1097-1103. PubMed ID: 22977627
[TBL] [Abstract][Full Text] [Related]
6. Mutation profile of KRAS and BRAF genes in patients with colorectal cancer: association with morphological and prognostic criteria.
Samara M; Kapatou K; Ioannou M; Kostopoulou Ε; Papamichali R; Papandreou C; Athanasiadis A; Koukoulis G
Genet Mol Res; 2015 Dec; 14(4):16793-802. PubMed ID: 26681025
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.
Arnold D; Lueza B; Douillard JY; Peeters M; Lenz HJ; Venook A; Heinemann V; Van Cutsem E; Pignon JP; Tabernero J; Cervantes A; Ciardiello F
Ann Oncol; 2017 Aug; 28(8):1713-1729. PubMed ID: 28407110
[TBL] [Abstract][Full Text] [Related]
8. Ex Vivo Human Colon Tissue Exposure to Pristine Graphene Activates Genes Involved in the Binding, Adhesion and Proliferation of Epithelial Cells.
Lahiani MH; Gokulan K; Williams K; Khare S
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768873
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma.
Apostolou P; Iliopoulos AC; Parsonidis P; Papasotiriou I
Oncotarget; 2019 May; 10(36):3328-3338. PubMed ID: 31164955
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of mRNA-decapping enzyme 1a affects survival rate in colorectal carcinoma.
Wu C; Liu W; Ruan T; Zhu X; Tao K; Zhang W
Oncol Lett; 2018 Jul; 16(1):1095-1100. PubMed ID: 29963186
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Cancer: Why Does Side Matter?
Gallois C; Pernot S; Zaanan A; Taieb J
Drugs; 2018 Jun; 78(8):789-798. PubMed ID: 29790124
[TBL] [Abstract][Full Text] [Related]
12. EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function.
Huang CW; Chen YT; Tsai HL; Yeh YS; Su WC; Ma CJ; Tsai TN; Wang JY
Oncotarget; 2017 Dec; 8(70):114663-114676. PubMed ID: 29383110
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.
Zeng JH; Liang L; He RQ; Tang RX; Cai XY; Chen JQ; Luo DZ; Chen G
Oncotarget; 2017 Mar; 8(10):16811-16828. PubMed ID: 28187432
[TBL] [Abstract][Full Text] [Related]
14. Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysis.
Shimamoto Y; Nukatsuka M; Takechi T; Fukushima M
Int J Mol Med; 2016 Feb; 37(2):319-28. PubMed ID: 26676887
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer.
Baba H; Watanabe M; Okabe H; Miyamoto Y; Sakamoto Y; Baba Y; Iwatsuki M; Chikamoto A; Beppu T
Br J Cancer; 2012 Dec; 107(12):1950-5. PubMed ID: 23169295
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase in patients with colorectal cancer.
Goto T; Shinmura K; Yokomizo K; Sakuraba K; Kitamura Y; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2012 May; 32(5):1757-62. PubMed ID: 22593457
[TBL] [Abstract][Full Text] [Related]
18. Determinants of prognosis and response to therapy in colorectal cancer.
Iqbal S; Lenz HJ
Curr Oncol Rep; 2001 Mar; 3(2):102-8. PubMed ID: 11177741
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
